These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 965155)

  • 1. Retro analogs related to oxytocin.
    Nakagawa SH; Yang F; Kato T; Flouret G; Hechter O
    Int J Pept Protein Res; 1976; 8(5):465-79. PubMed ID: 965155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of the peptide backbone to the action of oxytocin analogs.
    Hechter O; Kato T; Nakagawa SH; Yang F; Flouret G
    Proc Natl Acad Sci U S A; 1975 Feb; 72(2):563-6. PubMed ID: 164658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [1-Penicillamine,2-leucine]oxytocin. Synthesis and pharmacological and conformational studies of a potent peptide hormone inhibitor.
    Hruby VJ; Deb KK; Yamamoto DM; Hadley ME; Chan WY
    J Med Chem; 1979 Jan; 22(1):7-12. PubMed ID: 423185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and some pharmacological properties of [8-L-tryptophan]oxytocin.
    Bodanszky M; Tolle JC; Seto J; Sawyer WH
    J Med Chem; 1980 Nov; 23(11):1259-61. PubMed ID: 7452679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and some pharmacological properties of five analogs of oxytocin having L-homocysteine in position 6.
    Smith CW; Ferger MF
    J Med Chem; 1976 Feb; 19(2):250-4. PubMed ID: 1249804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (4-Phenylalanine)oxytocin, an inhibitor of the antidiuretic effect of 8-arginine-vasopressin.
    Nestor JJ; Ferger MF; Chan WY
    J Med Chem; 1975 Oct; 18(10):1022-4. PubMed ID: 1159680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [1-Deaminopenicillamine,4-threonine]oxytocin, a potent inhibitor of oxytocin.
    Manning M; Lowbridge J; Seto J; Haldar J; Sawyer WH
    J Med Chem; 1978 Feb; 21(2):179-82. PubMed ID: 621712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformationally restricted analogs of oxytocin; stabilization of inhibitory conformation.
    Lebl M; Hill P; Kazmierski W; Kárászová L; Slaninová J; Fric I; Hruby VJ
    Int J Pept Protein Res; 1990 Oct; 36(4):321-30. PubMed ID: 2079387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (1-Beta-mercaptopropionic acid, 2-(3,5-dibromo-L-tyrosine))oxytocin, a potent inhibitor of oxytocin.
    Lundell EO; Ferger MF
    J Med Chem; 1975 Oct; 18(10):1045-7. PubMed ID: 1159688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biofunctional evaluation of a hydrogen bond linking the ring and tail beta-turns of oxytocin.
    Roy J; Roy U; Gazis DC; Schwartz IL
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3309-13. PubMed ID: 291004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformationally biased analogs of oxytocin.
    Lebl M; Toth G; Slaninová J; Hruby VJ
    Int J Pept Protein Res; 1992 Aug; 40(2):148-51. PubMed ID: 1446971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desaminopenicillamine tocinoic acid derivatives--inhibitors of oxytocin.
    Roy U; Gazis D; Glass JD; Schwartz IL
    Int J Pept Protein Res; 1986 Aug; 28(2):154-62. PubMed ID: 3771100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and some pharmacological properties of two new antagonists of oxytocin.
    Rekowski P; Melin P; Lammek B
    Pol J Pharmacol Pharm; 1987; 39(3):303-7. PubMed ID: 3438212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacology of novel analogues of oxytocin and deaminooxytocin: directed methods for the construction of disulfide and trisulfide bridges in peptides.
    Chen L; Zoulíková I; Slaninová J; Barany G
    J Med Chem; 1997 Mar; 40(6):864-76. PubMed ID: 9083475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of oxytocin analogues containing conformationally-restricted residues in position 7.
    Fragiadaki M; Magafa V; Borovicková L; Slaninová J; Cordopatis P
    Eur J Med Chem; 2007 Jun; 42(6):799-806. PubMed ID: 17316912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and some pharmacological properties of [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine]oxytocin (hydroxy [4-thr]oxytocin), a peptide with strikingly high oxytocic potency and of [1-(L-2-hydroxy-3-mercaptopropanoic acid)]oxytocin (hydroxy-oxytocin).
    Manning M; Lowbridge J; Sawyer WH; Haldar J
    J Med Chem; 1976 Mar; 19(3):376-80. PubMed ID: 943546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [1-Beta-mercapto-beta,beta-pentamethylenepropionic acid]oxytocin, a potent inhibitor of oxytocin.
    Nestor JJ; Ferger MF; du Vigneaud V
    J Med Chem; 1975 Mar; 18(3):284-7. PubMed ID: 1133819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and some pharmacological properties of [1-beta-mercapto-beta,beta-diethylpropionic acid,2-(3,5-dibromo-L-tyrosine)]oxytocin.
    Lundell EO; Smith CW; Ferger MF
    J Med Chem; 1975 Dec; 18(12):1262-4. PubMed ID: 1195281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescent, photoaffinity, and biotinyl analogs of oxytocin.
    Buku A; Yamin N; Gazis D
    Peptides; 1988; 9(4):783-6. PubMed ID: 3226954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analogs of oxytocin containing a pseudopeptide Leu-Gly bond of cis and trans configuration.
    Lebl M; Slaninová J; Johnson RL
    Int J Pept Protein Res; 1989 Jan; 33(1):16-21. PubMed ID: 2722396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.